Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.79M Buy
13,946
+17
+0.1% +$1.99K 1.22% 27
2026
Q1
$1.68M Buy
13,929
+416
+3% +$48K 1.29% 28
2025
Q4
$1.42M Buy
13,513
+556
+4% +$52.2K 1.09% 28
2025
Q3
$1.09M Buy
12,957
+375
+3% +$30.9K 0.96% 35
2025
Q2
$996K Buy
12,582
+261
+2% +$20.7K 0.92% 39
2025
Q1
$1.11M Buy
12,321
+1,364
+12% +$127K 1.12% 30
2024
Q4
$1.09M Buy
+10,957
New +$1.13M 1.13% 31

Other funds holding MRK

Fjell Capital's MRK Position: Q2 2026 in Review

Fjell Capital increased its Merck (MRK) stake by 0.12% in Q2 2026, buying an estimated $1.99K and bringing the position to 13,946 shares worth $1.79M. The position accounts for 1.22% of the portfolio, ranked #27.

Fjell Capital first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Fjell Capital held 13,946 shares of Merck worth $1.79M as of Q2 2026.
  • Fjell Capital bought 17 Merck shares in Q2 2026, an estimated $1.99K.
  • Merck made up 1.22% of Fjell Capital's portfolio in Q2 2026, its #27 holding.
  • Fjell Capital first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Fjell Capital's 13F filing for Q2 2026, filed 15 Jul 2026.